Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate

Why did Trump fire the labor statistics chief? How will new tariffs impact US consumer prices? What caused Tesla's $329M Autopilot crash penalty? Why are US job growth numbers revised downward? How is Big Tech spending shaping the AI race? What effect do Trump tariffs have on global stocks? Why is Apple’s iPhone sales strong despite tariffs?

Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate

finance.yahoo.com/news/biogen-lifts-outlook-rare-disease-154958884.html

In This Article:
Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% year over year, beating the analyst consensus of $4.06.
The company reported sales of $2.65 billion, up 7% year over year on a reported basis, 8%…

This story appeared on finance.yahoo.com, 2025-07-31 15:49:58.